Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2003 Mar;20(3):406-8.
doi: 10.1023/a:1022652004114.

The mean dissolution time depends on the dose/solubility ratio

Affiliations

The mean dissolution time depends on the dose/solubility ratio

Eleni Rinaki et al. Pharm Res. 2003 Mar.

Abstract

Purpose: To investigate the relationship between mean dissolution time (MDT) and dose/solubility ratio (q) using the diffusion layer model.

Methods: Using the classic Noyes-Whitney equation and considering a finite dose, we derived an expression for MDT as a function of q under various conditions. q was expressed as a dimensionless quantity by taking into account the volume of the dissolution medium. Our results were applied to in vitro and in vivo data taken from literature.

Results: We found that MDT depends on q when q < 1 and is infinite when q > 1 and that the classic expression of MDT = 1/k. where k is the dissolution rate constant, holds only in the special case of q = 1. For the case of perfect sink conditions, MDT was found to be proportional to dose. Using dissolution data from literature with q < 1, we found better estimates of MDT when dependency on dose/ solubility ratio was considered than with the classic approach. Prediction of dissolution limited absorption was achieved for some of the in vivo drug examples examined.

Conclusion: The mean dissolution time of a drug depends on dose/ solubility ratio, even when the model considered is the simplest possible. This fact plays an important role in drug absorption when absorption is dissolution limited.

PubMed Disclaimer

References

    1. J Pharm Sci. 1985 Dec;74(12):1340-2 - PubMed
    1. J Pharmacokinet Biopharm. 1978 Dec;6(6):547-58 - PubMed
    1. Pharm Res. 1995 Mar;12(3):413-20 - PubMed
    1. J Pharm Sci. 1986 Feb;75(2):109-16 - PubMed
    1. Pharm Res. 1998 Mar;15(3):466-73 - PubMed

LinkOut - more resources